February 2, 2026: Brazilian Company May Offer Generic Semaglutide Drugs, Like Rybelsus Hypera, a drug company in Brazil, has announced plans to make a cheaper, generic version of semaglutide in March 2026, when Novo Nordisks patent protections expire in Brazil
SOS Glutathione Supplement A bright, even skin tone is often associated with health, vitality, and youth
Regulatory status Injectable GHK-Cu is not FDA-approved for any condition
All major clinical trials demonstrating significant weight loss used injectable formulations
Predictor of cognitive impairment: metabolic syndrome or circadian syndrome
The stronger association in females (HR 0.86) versus males (HR 0.97